Arineta, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, is announcing its partnership with Shandong Yituo Medical Technology Development Co. Ltd. (SYMT), a JMC-invested company. Its new joint venture company, Arineta (Shandong) Medical Equipment Co. Ltd., is anticipating the installation of its first
SpotLight™ Duo at a leading health system in Jinan, China, supporting the growing need for ultra-premium cardiac CT in China. Arineta’s FDA-cleared SpotLight Duo provides a single-beat, whole-heart scan optimized with 140mm coverage at a rotation speed of 0.24 sec per rotation. Its deep-learning imaging reconstruction (DLIR) technology provides superior image quality by reconstructing cross-sectional images, which allows for a more complete and accurate scan. The SpotLight Duo adds high-resolution thoracic clinical capabilities for lung cancer and other pulmonary diseases to its cardiovascular technology.
With China consistently in the top 10 countries with the highest incidence of cardiovascular disease (CVD) the introduction of Arineta’s advanced cardiovascular and thoracic imaging technology will support the need for ultra-premium cardiac and lung CT in the region. “For patients in need of cardiovascular and cardiothoracic imaging, the SpotLight Duo is the first dedicated cardiothoracic CT incorporating all of Arineta’s patient centric technologies,” said Doug Ryan, CEO of Arineta and the Chairman of the new JV Company. “With one heartbeat, we can provide both high-temporal and iso-temporal resolution images that can be used for comprehensive cardiac and thoracic CT assessment. At the same time, we are reducing radiation and contrast for scans while delivering more detailed and accurate images for better informed decision-making by physicians.”
“The establishment of the Arineta (Shandong) Medical Equipment Co. Ltd. in collaboration with our partners at SYMT based in the Jinan Medical Center in Shandong is a major milestone in the growth of Arienta and our commitment to Physicians and Patients in China to address their growing cardiothoracic care needs.”For more information, visit arineta.com.
About Arineta
Arineta is an Israeli company that develops and produces innovative cardiovascular imaging solutions. It is dedicated to growing cardiac CT as the front-line non-invasive test for diagnosing, therapy planning and monitoring of cardiovascular disease, the no. 1 cause of death and costs for healthcare worldwide. Arineta’s flagship product, SpotLight™ Duo, is the world’s first dedicated single-heartbeat, whole-heart cardiovascular and thoracic CT, based on the company’s proprietary Stereo CT technology. The company is part of a long tradition of medical imaging innovation that began in Israel in the 1970s. Among Arineta’s scientists are the inventors of the multi-slice spiral CT technology, still the cornerstone of CT imaging, and several other key technologies. For more information, visit arineta.com.
The Editorial Team at Healthcare Business Today is made up of skilled healthcare writers and experts, led by our managing editor, Daniel Casciato, who has over 25 years of experience in healthcare writing. Since 1998, we have produced compelling and informative content for numerous publications, establishing ourselves as a trusted resource for health and wellness information. We offer readers access to fresh health, medicine, science, and technology developments and the latest in patient news, emphasizing how these developments affect our lives.
